People news

Share this article:
Marinus Pharmaceuticals, a specialty therapeutics manufacturer, has appointed John Krayacich as president and CEO. Krayacich will be responsible for the business development of ganaxolone, an adult and pediatric epilepsy product currently in Phase II, as well as chelerythrine, a pre-clinical schizophrenia treatment.  

Contract research firm INC Research has promoted Nick Kenny, PhD, to senior vice president of oncology. Kenny was previously vice president of oncology.

The Cadient Group has appointed Todd Greene as strategic engagement director. Greene's position includes brand planning and strategic recommendations related to physician-patient dialogue for Cadient's clients. He will report to Linda Hutchins, group account director, at the New York City office.

Publicis Selling Solutions named Kevin Sharp director of client services. Sharp, who previously worked at Wyeth, was most recently head of an eponymous consultancy. The contract sales firm also named Sheena Rush client services administrator and Eileen Sigle business development analyst. 

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media